The European Commission has awarded funding to 17 research projects in a special call announced to tackle the coronavirus. IRB Barcelona’s Structural Bioinformatics and Network Biology Lab, headed by Patrick Aloy, is participating in one of these projects, together with other research centres. The project, called RiPCoN, will perform a computational study of the interactions between coronavirus and human cells, with the aim to identify drugs (already on the market or in trials) that can halt the spread of the virus.
Various media have reported on Spain’s participation in 6 of the 17 projects chosen by the European Commission to advance and speed up research into the coronavirus.
Link to: La Vanguardia
Link to: El Confidencial
Link to: Redacción Médica